BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28772167)

  • 21. Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling.
    Briolotti P; Chaloin L; Balaguer P; Da Silva F; Tománková V; Pascussi JM; Duret C; Fabre JM; Ramos J; Klieber S; Maurel P; Daujat-Chavanieu M; Gerbal-Chaloin S
    Toxicol Sci; 2015 Nov; 148(1):261-75. PubMed ID: 26259606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YAP Induces Human Naive Pluripotency.
    Qin H; Hejna M; Liu Y; Percharde M; Wossidlo M; Blouin L; Durruthy-Durruthy J; Wong P; Qi Z; Yu J; Qi LS; Sebastiano V; Song JS; Ramalho-Santos M
    Cell Rep; 2016 Mar; 14(10):2301-12. PubMed ID: 26947063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxicity and activation of the Wnt/beta-catenin pathway in mouse embryonic stem cells treated with four GSK3 inhibitors.
    Naujok O; Lentes J; Diekmann U; Davenport C; Lenzen S
    BMC Res Notes; 2014 Apr; 7():273. PubMed ID: 24779365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling.
    Park N; Baek HS; Chun YJ
    PLoS One; 2015; 10(8):e0134760. PubMed ID: 26252009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycogen synthase kinase 3 induces multilineage maturation of human pluripotent stem cell-derived lung progenitors in 3D culture.
    de Carvalho ALRT; Strikoudis A; Liu HY; Chen YW; Dantas TJ; Vallee RB; Correia-Pinto J; Snoeck HW
    Development; 2019 Jan; 146(2):. PubMed ID: 30578291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reprogramming of mouse somatic cells into pluripotent stem-like cells using a combination of small molecules.
    Kang PJ; Moon JH; Yoon BS; Hyeon S; Jun EK; Park G; Yun W; Park J; Park M; Kim A; Whang KY; Koh GY; Oh S; You S
    Biomaterials; 2014 Aug; 35(26):7336-45. PubMed ID: 24881998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synaptic stimulation of mTOR is mediated by Wnt signaling and regulation of glycogen synthetase kinase-3.
    Ma T; Tzavaras N; Tsokas P; Landau EM; Blitzer RD
    J Neurosci; 2011 Nov; 31(48):17537-46. PubMed ID: 22131415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.
    Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C
    Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of GSK3 and MEK induced cancer stem cell generation via the Wnt and MEK signaling pathways.
    Liao S; Gan L; Qin W; Liu C; Mei Z
    Oncol Rep; 2018 Oct; 40(4):2005-2013. PubMed ID: 30066938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of mTOR sensitizes breast cancer stem cells to radiation-induced repression of self-renewal through the regulation of MnSOD and Akt.
    Lai Y; Yu X; Lin X; He S
    Int J Mol Med; 2016 Feb; 37(2):369-77. PubMed ID: 26707081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of Akt isoforms on somatic cell reprogramming.
    Tang Y; Jiang Z; Luo Y; Zhao X; Wang L; Norris C; Tian XC
    J Cell Sci; 2014 Sep; 127(Pt 18):3998-4008. PubMed ID: 25037569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GSK3β Inhibition Promotes Efficient Myeloid and Lymphoid Hematopoiesis from Non-human Primate-Induced Pluripotent Stem Cells.
    D'Souza SS; Maufort J; Kumar A; Zhang J; Smuga-Otto K; Thomson JA; Slukvin II
    Stem Cell Reports; 2016 Feb; 6(2):243-56. PubMed ID: 26805448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking.
    Wieman HL; Wofford JA; Rathmell JC
    Mol Biol Cell; 2007 Apr; 18(4):1437-46. PubMed ID: 17301289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection.
    Chong ZZ; Li F; Maiese K
    Int J Mol Med; 2007 Feb; 19(2):263-72. PubMed ID: 17203200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
    Dokken BB; Sloniger JA; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels.
    Yang K; Guo Y; Stacey WC; Harwalkar J; Fretthold J; Hitomi M; Stacey DW
    BMC Cell Biol; 2006 Aug; 7():33. PubMed ID: 16942622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of antrocin from Antrodia camphorata as a selective and novel class of small molecule inhibitor of Akt/mTOR signaling in metastatic breast cancer MDA-MB-231 cells.
    Rao YK; Wu AT; Geethangili M; Huang MT; Chao WJ; Wu CH; Deng WP; Yeh CT; Tzeng YM
    Chem Res Toxicol; 2011 Feb; 24(2):238-45. PubMed ID: 21158420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway.
    Ohta E; Nihira T; Uchino A; Imaizumi Y; Okada Y; Akamatsu W; Takahashi K; Hayakawa H; Nagai M; Ohyama M; Ryo M; Ogino M; Murayama S; Takashima A; Nishiyama K; Mizuno Y; Mochizuki H; Obata F; Okano H
    Hum Mol Genet; 2015 Sep; 24(17):4879-900. PubMed ID: 26056228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of the treatment conditions with glycogen synthase kinase-3 inhibitor towards enhancing the proliferation of human induced pluripotent stem cells while maintaining an undifferentiated state under feeder-free conditions.
    Yoda K; Ohnuki Y; Kurosawa H
    J Biosci Bioeng; 2019 Mar; 127(3):381-387. PubMed ID: 30292671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.